HSCS
Heart Test Laboratories Inc. Common Stock
NASDAQ: HSCS · HEALTHCARE · MEDICAL DEVICES
$1.98
-1.00% today
Updated 2026-04-29
Market cap
$6.40M
P/E ratio
—
P/S ratio
738.41x
EPS (TTM)
$-4.49
Dividend yield
—
52W range
$2 – $6
Volume
0.0M
Heart Test Laboratories Inc. Common Stock (HSCS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-89,940.00%
ROE
-382.30%
ROA
-73.50%
Debt/equity
0.21x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $64182.00 | $-3.81M | -71.83% | -5,949.00% | -5,937.99% |
| 2021 | $25604.00 | $-2.45M | -72.93% | -10,030.18% | -9,577.29% |
| 2022 | $14373.00 | $-4.83M | -139.73% | -32,765.60% | -33,592.57% |
| 2023 | $5150.00 | $-6.35M | -476.91% | -118,698.33% | -123,384.27% |
| 2024 | $18600.00 | $-6.61M | -444.16% | -33,901.99% | -35,511.87% |
| 2025 | $4350.00 | $-8.77M | -2,884.71% | -192,013.13% | -201,499.52% |